Loading…

4-aminoquinoline analogues and its platinum (II) complexes as antimalarial agents

Abstract The high incidence of malaria and drug-resistant strains of Plasmodium have turned this disease into a problem of major health importance. One of the approaches used to control it is to search for new antimalarial agents, such as quinoline derivates. This class of compounds composes a broad...

Full description

Saved in:
Bibliographic Details
Published in:Biomedicine & pharmacotherapy 2011-07, Vol.65 (4), p.313-316
Main Authors: de Souza, Nicolli Bellotti, Carmo, Arturene M.L, Lagatta, Davi C, Alves, Márcio José Martins, Fontes, Ana Paula Soares, Coimbra, Elaine Soares, da Silva, Adilson David, Abramo, Clarice
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract The high incidence of malaria and drug-resistant strains of Plasmodium have turned this disease into a problem of major health importance. One of the approaches used to control it is to search for new antimalarial agents, such as quinoline derivates. This class of compounds composes a broad group of antimalarial agents, which are largely employed, and inhibits the formation of β-haematin (malaria pigment), which is lethal to the parasite. More specifically, 4-aminoquinoline derivates represent potential sources of antimalarials, as the example of chloroquine, the most used antimalarial worldwide. In order to assess antimalarial activity, 12 4-aminoquinoline derived drugs were obtained and some of these derivatives were used to obtain platinum complexes platinum (II). These compounds were tested in vivo in a murine model and revealed remarkable inhibition of parasite multiplication values, whose majority ranged from 50 to 80%. In addition they were not cytotoxic. Thus, they may be object of further research for new antimalarial agents.
ISSN:0753-3322
1950-6007
DOI:10.1016/j.biopha.2011.03.003